418 related articles for article (PubMed ID: 26819072)
21. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
22. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
[TBL] [Abstract][Full Text] [Related]
23. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
24. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
25. A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas.
Qiu Y; Yang J; Chen M; Chang L; Wang T; Ma G; Jin Y; Chen H; Lin X
J Dermatol; 2015 Apr; 42(4):363-6. PubMed ID: 25656976
[TBL] [Abstract][Full Text] [Related]
26. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
[TBL] [Abstract][Full Text] [Related]
27. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas.
Anwar F; Mahmood E; Sharif S; Shah R; Jamgochian M; Ouellette S; Umar M; Rao B
J Drugs Dermatol; 2023 Jun; 22(6):594-598. PubMed ID: 37276157
[TBL] [Abstract][Full Text] [Related]
28. Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH).
Boos MD; Castelo-Soccio L
J Am Acad Dermatol; 2016 Mar; 74(3):567-70. PubMed ID: 26892656
[No Abstract] [Full Text] [Related]
29. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
30. Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption.
Weibel L; Barysch MJ; Scheer HS; Königs I; Neuhaus K; Schiestl C; Rentsch K; Müller DM; Theiler M
Pediatr Dermatol; 2016; 33(2):184-90. PubMed ID: 26840644
[TBL] [Abstract][Full Text] [Related]
31. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
32. Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas.
Wu HW; Wang X; Zhang L; Zheng JW; Liu C; Wang YA
Front Oncol; 2018; 8():605. PubMed ID: 30619747
[No Abstract] [Full Text] [Related]
33. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma.
Frommelt P; Juern A; Siegel D; Holland K; Seefeldt M; Yu J; Uhing M; Wade K; Drolet B
Pediatr Dermatol; 2016 Jul; 33(4):405-14. PubMed ID: 27246751
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O
Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885
[TBL] [Abstract][Full Text] [Related]
35. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
36. A novel topical nano-propranolol for treatment of infantile hemangiomas.
Chen ZG; Zheng JW; Yuan ML; Zhang L; Yuan WE
Nanomedicine; 2015 Jul; 11(5):1109-15. PubMed ID: 25791814
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
38. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
39. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
[TBL] [Abstract][Full Text] [Related]
40. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas.
Chambers CB; Katowitz WR; Katowitz JA; Binenbaum G
Ophthalmic Plast Reconstr Surg; 2012; 28(2):103-6. PubMed ID: 22410658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
